Mirum Pharmaceuticals Inc (MIRM)
40.44
+0.04
(+0.10%)
USD |
NASDAQ |
Nov 04, 16:00
40.48
+0.04
(+0.10%)
After-Hours: 20:00
Mirum Pharmaceuticals Gross Profit Margin (Quarterly): 74.03% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 74.03% |
| March 31, 2024 | 74.24% |
| December 31, 2023 | 64.03% |
| September 30, 2023 | 78.57% |
| June 30, 2023 | 81.83% |
| March 31, 2023 | 84.24% |
| Date | Value |
|---|---|
| December 31, 2022 | 83.90% |
| September 30, 2022 | 84.39% |
| June 30, 2022 | 85.56% |
| March 31, 2022 | 81.20% |
| December 31, 2021 | 39.36% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
39.36%
Minimum
Dec 2021
85.56%
Maximum
Jun 2022
75.58%
Average
81.20%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
| Cytokinetics Inc | -31.87K% |
| MannKind Corp | 71.85% |
| TG Therapeutics Inc | 88.70% |
| Ocugen Inc | -- |
| Rhythm Pharmaceuticals Inc | 89.87% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.49% |
| Return on Assets | -17.87% |
| Return on Invested Capital | -21.06% |
| Profit Margin (Quarterly) | -31.64% |
| Operating Margin (Quarterly) | -31.12% |
| Return on Net Operating Assets | -37.22% |